Working on biomarkers for Biliary Atresia

Two studies have tried to identify biomarkers to facilitate the diagnosis of biliary atresia (BA).

  • JPGN 2012; 55: 366-69
  • JPGN 2012; 55: 370-75

The first study looks at the serum of 24 patients with BA & 24 cholestatic controls.  Several circulating microRNAs (miRNAs) were associated with BA.  The miR-200b/429 cluster could correctly classify up to 85% of patients.

The second study took serum samples from 42 infants with BA, 38 infants with non-BA cholestasis, and 36 healthy controls.  Using mass spectrometry and enzyme-linked immunosorbent assays, they identified a candidate biomarker, Apo C-II, which was down-regulated in BA samples compared to healthy controls, but relatively upregulated compared with cholestatic non-BA samples.  The sensitivity of this model was 94% and the specificity was 92%.

Given the consequence of a missed diagnosis of BA, further work to identify biomarkers with even better sensitivity/specificity will be necessary to change current diagnostic algorithms.

Previous related blog entries:

4 thoughts on “Working on biomarkers for Biliary Atresia

  1. Pingback: Learning a lot from ChiLDREN (part 2) | gutsandgrowth

  2. Pingback: Biliary Atresia More Common in Preterm Infants | gutsandgrowth

  3. Pingback: Reclassifying Biliary Atresia -Three Subtypes | gutsandgrowth

  4. Pingback: START Study: Steroids Not Effective For Biliary Atresia (After Kasai) | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.